You are here

Our science / Clinical Trials / Find a Trial / NCT00723021

PF-04191834 Single Dose Bronchodilatory Study In Asthma.

Back to Search Print Save as PDF Bookmark Trial

NCT00723021

Last updated on February 20, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Baltimore, Maryland, 21225 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Asthma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-60 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Persistent mild/moderate asthma for at least 6 months.

- Reduced lung function

- Reversible airway obstruction

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnant/nursing females.

- Liver function tests greater than upper limit of normal (ULN)

NCT00723021
Pfizer
Completed
PF-04191834 Single Dose Bronchodilatory Study In Asthma.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Asthma
Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma
NCT00725582
All Genders
Asthma
To Test The Relative Bioavailability Of PF-04191834 When Dosed As An Immediate Release Tablet Compared With Solution Following Single And Multiple Dosing
NCT01064804
Males
21+
Years
Bruxelles,
Asthma
A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
NCT00150397
All Genders
18+
Years
Multiple Sites
Asthma
An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
NCT02219048
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now